Clinical Trials
10 trialsNCT00295893 2025-09-25
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT00820547 2019-10-22
Beverly1
UNICANCER
Phase 2 Completed
NCT00820872 2019-10-21
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00852332 2018-07-24
Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Centre Jean Perrin
Phase 2 Terminated
NCT00079118 2016-12-13
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00088998 2016-12-07
Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00107510 2016-07-06
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00054275 2016-02-17
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00027885 2013-06-17
Phase II Bevacizumab + Tax In Advanced Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00044993 2013-05-30
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed